VOYA Investment Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Buy |
|
|||||
|
2025
Q1 | $2.89M | Sell |
|
|||||
|
2024
Q4 | $3.19M | Sell |
|
|||||
|
2024
Q3 | $5.12M | Buy |
|
|||||
|
2024
Q2 | $2.25M | Sell |
|
|||||
|
2024
Q1 | $2.01M | Buy |
|
|||||
|
2023
Q4 | $992K | Buy |
|
|||||
|
2023
Q3 | $717K | Buy |
|
|||||
|
2023
Q2 | $1.15M | Sell |
|
|||||
|
2023
Q1 | $2.16M | Sell |
|
|||||
|
2022
Q4 | $1.52M | Sell |
|
|||||
|
2022
Q3 | $1.23M | Buy |
|
|||||
|
2022
Q2 | $137K | Hold |
|
|||||
|
2022
Q1 | $411K | Hold |
|
|||||
|
2021
Q4 | $594K | Sell |
|
|||||
|
2021
Q3 | $309K | Buy |
|
|||||
|
2021
Q2 | $729K | Buy |
|
|||||
|
2021
Q1 | $391K | Buy |
|
|||||
|
2020
Q4 | $264K | Buy |
|
|||||
|
2020
Q3 | $196K | Buy |
|